First-in-human in vivo genome editing via AAV-zinc-finger nucleases for mucopolysaccharidosis I/II and hemophilia B

Authors:

Abstract
No abstract available
Funding Information
  • Sangamo Therapeutics

This publication has 45 references indexed in Scilit: